Skip to main content
Caplight Logo









Leukocare

Leukocare

Private
GermanyHealthcare & Life Scienceshttps://www.leukocare.com/

Last Round

VC Round

Jun 23, 2021

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Leukocare is a biotechnology company that provides a technology platform for biopharmaceutical formulation development to improve the stability and quality of biologics like vaccines, antibodies, and viral vectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

formulation developmentbiopharmaceutical formulationbiologic stabilitylyophilization servicesfreeze-dryingcontract research organizationCROCDMOviral vector formulationvaccine formulationadvanced therapy medicinal productsATMPsAI for drug formulationstability studiesbioinformatics servicesexcipient selectionprimary packaging services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leukocare Comparables

Compare Leukocare with similar companies based on industry and business-model similarity.

Leukocare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProJect Pharmaceutics GmbH
87%
Coriolis Pharma
87%
Pensatech Pharma GmbH
74%

Leukocare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 23, 2021
VC RoundJul 22, 2015

Key People

Founding team and executive leadership

Michael Scholl

CEO

Executive Team

Leukocare Investors

Notable investors and investment history

Leukocare investors
InvestorRounds
LifeCare PartnersVC Round
Petrichor Healthcare Capital ManagementVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 59% MoM.

  • Aug 1, 2026

    Open roles increased to 46, 82% of headcount.

Leukocare Filings

Explore SEC and related filing metadata, where available.

Leukocare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Leukocare's valuation, stock price, and market status.

Is Leukocare a public or private company?

Leukocare is a private company.

What is the current stock price of Leukocare?

Leukocare is a private company with no public stock price. No recent secondary market data is available.

How much is Leukocare worth (valuation)?

Valuation information for Leukocare is not publicly available.

Can I buy Leukocare stock?

Leukocare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Leukocare's last funding round?

Funding round information for Leukocare is not publicly available.

Who are the main investors in Leukocare?

Investor information for Leukocare is not publicly disclosed.

Will Leukocare IPO soon?

No public IPO plans have been announced for Leukocare.

How can I track Leukocare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Leukocare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGermany
Employee Range55
Year Founded2003
Last FundingJun 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?